Novartis (SWX:NOVN) has recorded its 29th consecutive annual dividend increase, extending a nearly three decade payout track ...

This report provides an in-depth analysis of the Cell and Gene Therapy industry, highlighting key company revenues, ...

The global preclinical imaging market is experiencing significant growth, propelled by increased R&D spending, adoption of ...

As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage ...

An ELRIG conference bringing together academic and industry leaders to explore the translational challenge of advancing cell ...

More than two years after its approval, only about 60 patients across the U.S., Middle East, and Europe have been treated ...

Gene therapy is a medical treatment that works by changing or fixing a person's genes to treat or prevent disease ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...